| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCIENCE.7725107 |
| P698 | PubMed publication ID | 7725107 |
| P2093 | author name string | Huber R | |
| Baumeister W | |||
| Seemüller E | |||
| Lupas A | |||
| Stock D | |||
| Löwe J | |||
| P433 | issue | 5210 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 579-582 | |
| P577 | publication date | 1995-04-01 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Proteasome from Thermoplasma acidophilum: a threonine protease | |
| P478 | volume | 268 |
| Q31135030 | 'Species' of peptidases |
| Q36869057 | 1,10-Phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome activity. |
| Q50740999 | 20S proteasomes have the potential to keep substrates in store for continual degradation. |
| Q57088438 | A comparison of the crystal structures of bacterial l-asparaginases |
| Q27733238 | A covalently bound catalytic intermediate in Escherichia coli asparaginase: crystal structure of a Thr-89-Val mutant |
| Q48063552 | A hyperthermostable protease of the subtilisin family bound to the surface layer of the archaeon Staphylothermus marinus |
| Q40324090 | A mathematical model of protein degradation by the proteasome |
| Q39679563 | A membrane-bound archaeal Lon protease displays ATP-independent proteolytic activity towards unfolded proteins and ATP-dependent activity for folded proteins |
| Q36900376 | A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cells |
| Q34347861 | A novel role of proteasomal β1 subunit in tumorigenesis |
| Q59098628 | A proteolytic system that compensates for loss of proteasome function |
| Q73327194 | A short cut for the immune system |
| Q53007185 | A third interferon-gamma-induced subunit exchange in the 20S proteasome. |
| Q36690211 | A unified mechanism for proteolysis and autocatalytic activation in the 20S proteasome. |
| Q38575440 | A voyage to the inner space of cells |
| Q44283109 | ATP hydrolysis by the proteasome regulatory complex PAN serves multiple functions in protein degradation |
| Q34718753 | ATP-dependent proteinases in bacteria. |
| Q52312617 | Activation of glycosylasparaginase. Formation of active N-terminal threonine by intramolecular autoproteolysis. |
| Q73797112 | Active site-directed inhibitors of Rhodococcus 20 S proteasome. Kinetics and mechanism |
| Q73911130 | Aldehyde and phosphinate analogs of glutathione and glutathionylspermidine: potent, selective binding inhibitors of the E. coli bifunctional glutathionylspermidine synthetase/amidase |
| Q33873082 | An archaebacterial ATPase, homologous to ATPases in the eukaryotic 26 S proteasome, activates protein breakdown by 20 S proteasomes |
| Q42155574 | An economical method for production of (2)H, (13)CH3-threonine for solution NMR studies of large protein complexes: application to the 670 kDa proteasome |
| Q38294064 | Analysis of Drosophila 26 S proteasome using RNA interference |
| Q24561722 | Analysis of mammalian 20S proteasome biogenesis: the maturation of beta-subunits is an ordered two-step mechanism involving autocatalysis |
| Q35638338 | Anti-proteasome autoantibodies contribute to anti-nuclear antibody patterns on human larynx carcinoma cells. |
| Q34801818 | Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways |
| Q32039364 | Archaeal proteasomes |
| Q37606188 | Archaeal proteasomes and sampylation |
| Q40263720 | Archaeal proteasomes effectively degrade aggregation-prone proteins and reduce cellular toxicities in mammalian cells |
| Q35209250 | Archaeal proteasomes: potential in metabolic engineering |
| Q34418425 | Archaeal proteasomes: proteolytic nanocompartments of the cell |
| Q34207253 | Asparagine peptide lyases: a seventh catalytic type of proteolytic enzymes |
| Q37815407 | Aspartic proteinases from Mucor spp. in cheese manufacturing |
| Q38090856 | Assembly of the 20S proteasome. |
| Q33654839 | Assembly of the regulatory complex of the 26S proteasome |
| Q40658937 | Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates |
| Q40839103 | Association of immunoproteasomes with the endoplasmic reticulum |
| Q47853840 | Autocatalytic processing of the 20S proteasome |
| Q27931608 | Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly |
| Q27681206 | Autoproteolytic Activation of ThnT Results in Structural Reorganization Necessary for Substrate Binding and Catalysis |
| Q26778726 | Bacterial Proteasomes |
| Q34161423 | Beta 2 subunit propeptides influence cooperative proteasome assembly |
| Q41487679 | Bifunctional quorum-quenching and antibiotic-acylase MacQ forms a 170-kDa capsule-shaped molecule containing spacer polypeptides |
| Q30724510 | Biochemical analysis of the 20 S proteasome of Trypanosoma brucei |
| Q33726998 | Biochemical characterization of the 20S proteasome from the methanoarchaeon Methanosarcina thermophila |
| Q48708926 | Bovine spleen multicatalytic proteinase complex (proteasome). Replacement of X, Y, and Z subunits by LMP7, LMP2, and MECL1 and changes in properties and specificity |
| Q37036656 | Broad-spectrum antimalarial activity of peptido sulfonyl fluorides, a new class of proteasome inhibitors. |
| Q61941012 | Catalytic Properties of 26 S and 20 S Proteasomes and Radiolabeling of MB1, LMP7, and C7 Subunits Associated with Trypsin-like and Chymotrypsin-like Activities |
| Q39446473 | Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival |
| Q34473291 | Cellular and computational studies of proteasome inhibition and apoptosis induction in human cancer cells by amino acid Schiff base-copper complexes. |
| Q46987054 | Characterization of a multicatalytic proteinase complex (20S proteasome) from Trypanosoma brucei brucei |
| Q42158512 | Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cells |
| Q47889177 | Characterization of the 20S proteasome from the actinomycete Frankia |
| Q41787383 | Characterization of the proteasome from the extremely halophilic archaeon Haloarcula marismortui |
| Q28346508 | Chemical denaturation and elevated folding temperatures are required for wild-type activity and stability of recombinant Methanococcus jannaschii 20S proteasome |
| Q37385647 | Chromosomal localization of the proteasome Z subunit gene reveals an ancient chromosomal duplication involving the major histocompatibility complex |
| Q41052878 | Circular assemblies |
| Q33902989 | Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin, and protein substrates of proteasome. |
| Q21195237 | Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells |
| Q36867421 | Cloning and characterization of mouse Lmp3 cDNA, encoding a proteasome beta subunit |
| Q34545646 | Clp ATPases and their role in protein unfolding and degradation |
| Q33884616 | Comparative activities of nickel(II) and zinc(II) complexes of asymmetric [NN'O] ligands as 26S proteasome inhibitors. |
| Q35832539 | Computational modeling of the potential interactions of the proteasome beta5 subunit and catechol-O-methyltransferase-resistant EGCG analogs. |
| Q24336801 | Constitutive and interferon-gamma-induced expression of the human proteasome subunit multicatalytic endopeptidase complex-like 1 |
| Q34753108 | Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants |
| Q41066929 | Control of gene expression by proteolysis |
| Q71254579 | Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands |
| Q36237082 | Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors |
| Q60952470 | Cryo-EM structures of the archaeal PAN-proteasome reveal an around-the-ring ATPase cycle |
| Q27628834 | Crystal and solution structures of an HslUV protease-chaperone complex |
| Q42162926 | Crystallization and preliminary X-ray analysis of the Thermoplasma acidophilum 20S proteasome in complex with protein substrates |
| Q36916903 | Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo |
| Q47310409 | Cutting complexity down to size. |
| Q77317960 | Decelerated degradation of short peptides by the 20S proteasome |
| Q43855407 | Development and evaluation of a sandwich ELISA for quantification of the 20S proteasome in human plasma |
| Q62856559 | Differences in Catalytic Activities and Subunit Pattern of Multicatalytic Proteinase Complexes (Proteasomes) Isolated from Bovine Pituitary, Lung, and Liver |
| Q73981359 | Dissecting the assembly pathway of the 20S proteasome |
| Q28286706 | Divergent intron arrangement in the MB1/LMP7 proteasome gene pair |
| Q36909248 | Diversity of proteasomal missions: fine tuning of the immune response |
| Q24616455 | EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment |
| Q38362387 | Echinococcus granulosus antigen 5 is closely related to proteases of the trypsin family |
| Q42460522 | Effects of the cys mutations on structure and function of the ATP-dependent HslVU protease in Escherichia coli. The Cys287 to Val mutation in HslU uncouples the ATP-dependent proteolysis by HslvU from ATP hydrolysis |
| Q38089497 | Efficacy of bortezomib as first-line treatment for patients with multiple myeloma |
| Q38315475 | Essential role of human leukocyte antigen-encoded proteasome subunits in NF-kappaB activation and prevention of tumor necrosis factor-alpha-induced apoptosis |
| Q41535709 | Eubacterial proteasomes |
| Q47334822 | Evidence for the existence of both proteasomes and a novel high molecular weight peptidase in Entamoeba histolytica |
| Q41018629 | Evidence for the participation of the proteasome and calpain in early phases of muscle cell differentiation |
| Q27480313 | Evidence that flavivirus NS1-NS2A cleavage is mediated by a membrane-bound host protease in the endoplasmic reticulum |
| Q35060162 | Evolution of the thermopsin peptidase family (A5) |
| Q28248267 | Expression and subcellular localization of mouse 20S proteasome activator complex PA28 |
| Q48069099 | Expression of an archaeal chaperonin in E. coli: formation of homo- (alpha, beta) and hetero-oligomeric (alpha+beta) thermosome complexes. |
| Q64267639 | Fast Amide Bond Cleavage Assisted by a Secondary Amino and a Carboxyl Group-A Model for yet Unknown Peptidases? |
| Q35851826 | Functional analyses of active site residues of human lysosomal aspartylglucosaminidase: implications for catalytic mechanism and autocatalytic activation |
| Q37365069 | Fundamental reaction pathway for peptide metabolism by proteasome: insights from first-principles quantum mechanical/molecular mechanical free energy calculations |
| Q37831836 | Fungal proteases and their pathophysiological effects |
| Q42661677 | Further sequence analysis of the DNA regions with the Rhodococcus 20S proteasome structural genes reveals extensive homology with Mycobacterium leprae |
| Q41722133 | Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules. |
| Q35135845 | Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. [corrected]. |
| Q33993001 | Halophilic 20S proteasomes of the archaeon Haloferax volcanii: purification, characterization, and gene sequence analysis |
| Q38177328 | Harnessing proteasome dynamics and allostery in drug design. |
| Q34733264 | HslV-HslU: A novel ATP-dependent protease complex in Escherichia coli related to the eukaryotic proteasome |
| Q37446205 | HslVU ATP-dependent protease utilizes maximally six among twelve threonine active sites during proteolysis |
| Q41533232 | Human Tumor Antigens and Cancer Immunotherapy |
| Q34737513 | Identification and characterization of HsIV HsIU (ClpQ ClpY) proteins involved in overall proteolysis of misfolded proteins in Escherichia coli. |
| Q35972023 | Identification of an activation region in the proteasome activator REGalpha |
| Q48315604 | Identification of the 19S regulatory particle subunits from the rice 26S proteasome |
| Q27932645 | Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation |
| Q36381008 | Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits |
| Q34801742 | Impairment of proteasome structure and function in aging. |
| Q41034976 | Inactivation of a defined active site in the mouse 20S proteasome complex enhances major histocompatibility complex class I antigen presentation of a murine cytomegalovirus protein. |
| Q50072067 | Infection with Salmonella typhimurium has no effect on the composition and cleavage specificity of the 20S proteasome in human lymphoid cells |
| Q77907913 | Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome |
| Q35832076 | Inhibition of catechol-Omicron-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (-)-EGCG. |
| Q28300614 | Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin |
| Q47987649 | Inhibition of the Proteasome β2 Site Sensitizes Triple-Negative Breast Cancer Cells to β5 Inhibitors and Suppresses Nrf1 Activation |
| Q37158093 | Inhibition of tumor proteasome activity by gold-dithiocarbamato complexes via both redox-dependent and -independent processes |
| Q38019864 | Inhibitors for the immuno- and constitutive proteasome: current and future trends in drug development |
| Q37851050 | Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes |
| Q33887390 | Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor beta subunits |
| Q47714778 | Intracellular proteinases of invertebrates: calcium-dependent and proteasome/ubiquitin-dependent systems |
| Q26781998 | Intrinsic evolutionary constraints on protease structure, enzyme acylation, and the identity of the catalytic triad |
| Q30584585 | Intrinsic nucleoside diphosphate kinase-like activity is a novel function of the 20 S proteasome |
| Q27640607 | Investigations on the maturation and regulation of archaebacterial proteasomes |
| Q42583535 | Involvement of a eukaryotic-like ubiquitin-related modifier in the proteasome pathway of the archaeon Sulfolobus acidocaldarius. |
| Q38932916 | L-Ornithine Schiff base-copper and -cadmium complexes as new proteasome inhibitors and apoptosis inducers in human cancer cells. |
| Q41320609 | LMP2+ proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes. |
| Q41109895 | Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation |
| Q48647682 | Learning from the Proteasome How To Fine-Tune Cancer Immunotherapy |
| Q45112763 | Localization and expression of TSP50 protein in human and rodent testes |
| Q35187221 | Managing peptidases in the genomic era. |
| Q44086498 | Mechanism of antigen presentation after hypertonic loading of soluble antigens |
| Q24564109 | Mechanism of gate opening in the 20S proteasome by the proteasomal ATPases |
| Q35171777 | Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma |
| Q34000314 | Metal-based 2,3-indolinedione derivatives as proteasome inhibitors and inducers of apoptosis in human cancer cells |
| Q30336310 | Metal-chelating amino acids as building blocks for synthetic receptors sensing metal ions and histidine-tagged proteins. |
| Q77859519 | Modulators of the activation of the proteasome by PA28 (11S reg) |
| Q35107681 | Molecular architecture of the ATP-dependent CodWX protease having an N-terminal serine active site |
| Q48050255 | Molecular cloning of the mouse proteasome subunits MC14 and MECL-1: reciprocally regulated tissue expression of interferon-gamma-modulated proteasome subunits |
| Q36023030 | Molecular machines for protein degradation |
| Q41197256 | Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation |
| Q34604536 | Molecular organization of the 20S proteasome gene family from Arabidopsis thaliana. |
| Q54561939 | Mutagenesis of two N-terminal Thr and five Ser residues in HslV, the proteolytic component of the ATP-dependent HslVU protease. |
| Q71929561 | Mutational analysis of the ATP-binding site in HslU, the ATPase component of HslVU protease in Escherichia coli |
| Q47792471 | Mutations in the yeast proteasome beta-type subunit Pre3 uncover position-dependent effects on proteasomal peptidase activity and in vivo function |
| Q28590361 | Myogenin protein stability is decreased by BMP-2 through a mechanism implicating Id1 |
| Q81697676 | Native protein nanolithography that can write, read and erase |
| Q37311396 | Natural polyphenols as proteasome modulators and their role as anti-cancer compounds. |
| Q47285155 | Natural selection during functional divergence to LMP7 and proteasome subunit X (PSMB5) following gene duplication |
| Q24322943 | Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma |
| Q36784772 | Next Generation Sequencing Identifies Five Major Classes of Potentially Therapeutic Enzymes Secreted by Lucilia sericata Medical Maggots |
| Q37189804 | Novel 8-hydroxylquinoline analogs induce copper-dependent proteasome inhibition and cell death in human breast cancer cells. |
| Q28277275 | Nuclear localization signals of human and Thermoplasma proteasomal alpha subunits are functional in vitro |
| Q27636245 | Nucleotide-dependent conformational changes in a protease-associated ATPase HsIU |
| Q28397872 | Organic cadmium complexes as proteasome inhibitors and apoptosis inducers in human breast cancer cells |
| Q73135763 | PAN, the proteasome-activating nucleotidase from archaebacteria, is a protein-unfolding molecular chaperone |
| Q33838858 | Participation of the sperm proteasome during in vitro fertilisation and the acrosome reaction in cattle |
| Q47434235 | Peptide splicing by the proteasome |
| Q41957197 | Phosphorylation and methylation of proteasomal proteins of the haloarcheon Haloferax volcanii |
| Q24522630 | Phosphorylation of nuclear MyoD is required for its rapid degradation |
| Q36380352 | Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system |
| Q41053715 | Processing and delivery of peptides presented by MHC class I molecules |
| Q37606186 | Prokaryotic proteasomes: nanocompartments of degradation |
| Q77985203 | Proteases in cellular regulation minireview series |
| Q38337481 | Proteasome activation by REG molecules lacking homolog-specific inserts |
| Q28290599 | Proteasome activator (PA28) subunits, alpha, beta and gamma (Ki antigen) in NT2 neuronal precursor cells and HeLa S3 cells |
| Q37826501 | Proteasome activators |
| Q42943799 | Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus |
| Q28245575 | Proteasome assembly |
| Q52172227 | Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: insights into specificity and potency. |
| Q40853921 | Proteasome inhibitors block the entry of liposome-encapsulated antigens into the classical MHC class I pathway |
| Q45114016 | Proteasome inhibitors prevent tracheary element differentiation in zinnia mesophyll cell cultures |
| Q34052405 | Proteasome inhibitors: from in vitro uses to clinical trials |
| Q34341985 | Proteasome inhibitors: from research tools to drug candidates |
| Q29620573 | Proteasome inhibitors: valuable new tools for cell biologists |
| Q38269935 | Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex |
| Q40476345 | Proteasome: a complex protease with a new fold and a distinct mechanism |
| Q41080732 | Proteasome: from structure to function |
| Q33542295 | Proteasomes and other self-compartmentalizing proteases in prokaryotes |
| Q36597934 | Proteasomes from structure to function: perspectives from Archaea |
| Q48888898 | Proteasomes in human spermatozoa |
| Q53354360 | Proteasomes in immune cells: more than peptide producers? |
| Q35904377 | Proteasomes play an essential role in thymocyte apoptosis |
| Q34700398 | Protein degradation and the generation of MHC class I-presented peptides. |
| Q41535659 | Protein degradation by the proteasome and dissection of its in vivo importance with synthetic inhibitors |
| Q41288801 | Proteolysis in plants: mechanisms and functions |
| Q40427886 | Proteolysis: The proteasome: a protein-degrading organelle? |
| Q99584387 | Proteolytic systems of archaea: slicing, dicing, and mincing in the extreme |
| Q34424057 | Purification and Characterization of a Proteasome from the Hyperthermophilic Archaeon Pyrococcus furiosus. |
| Q36820514 | Purification and characterization of proteasomes from Trypanosoma brucei |
| Q46653814 | Purification and characterization of the 20S proteasome from ostrich skeletal muscle |
| Q34384407 | Purification and characterization of the heat shock proteins HslV and HslU that form a new ATP-dependent protease in Escherichia coli |
| Q34298336 | Puromycin-sensitive aminopeptidase. Sequence analysis, expression, and functional characterization |
| Q37148849 | Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity |
| Q24616890 | Recent advances on tea polyphenols |
| Q33992310 | Redundant in vivo proteolytic activities of Escherichia coli Lon and the ClpYQ (HslUV) protease. |
| Q28116400 | Regulation of CD8+ T cell development by thymus-specific proteasomes |
| Q46203071 | Regulation of Protein Degradation |
| Q34633196 | Regulation of apoptosis by the ubiquitin and proteasome pathway. |
| Q28244142 | Regulation of proteasome structure and function |
| Q58774592 | Reporter PET Images Bortezomib Treatment-Mediated Suppression of Cancer Cell Proteasome Activity |
| Q39739226 | Rethinking proteasome evolution: two novel bacterial proteasomes |
| Q56866496 | Review |
| Q44727087 | Role of C-terminal extensions of subunits beta2 and beta7 in assembly and activity of eukaryotic proteasomes. |
| Q36181377 | Selective proteasome inhibitors as anti-inflammatory agents |
| Q41633142 | Self-compartmentalizing proteases. |
| Q43868830 | Sequencing of amphioxus PSMB5/8 gene and phylogenetic position of agnathan sequences |
| Q72033286 | Sighting the cellular shredder |
| Q34737150 | Six-fold rotational symmetry of ClpQ, the E. coli homolog of the 20S proteasome, and its ATP-dependent activator, ClpY. |
| Q54097243 | Species variation in ATP-dependent protein degradation: protease profiles differ between mycobacteria and protease functions differ between Mycobacterium smegmatis and Escherichia coli. |
| Q71824471 | Specific inhibition of the chymotrypsin-like activity of the proteasome induces a bipolar morphology in neuroblastoma cells |
| Q31096459 | Specific orientation and two-dimensional crystallization of the proteasome at metal-chelating lipid interfaces |
| Q47919213 | Stress induction of the Bacillus subtilis clpP gene encoding a homologue of the proteolytic component of the Clp protease and the involvement of ClpP and ClpX in stress tolerance |
| Q27661050 | Structural Basis for the Activity and Substrate Specificity of Fluoroacetyl-CoA Thioesterase FlK |
| Q27658058 | Structural Models for Interactions between the 20S Proteasome and Its PAN/19S Activators |
| Q33548213 | Structural and energetic determinants of the S1-site specificity in serine proteases |
| Q47944567 | Structural and functional analysis of the six regulatory particle triple-A ATPase subunits from the Arabidopsis 26S proteasome |
| Q27661499 | Structural basis for the assembly and gate closure mechanisms of the Mycobacterium tuberculosis 20S proteasome |
| Q38081952 | Structural biology of the proteasome |
| Q37396451 | Structural insights into proteasome activation by the 19S regulatory particle |
| Q37640400 | Structural insights into the functional cycle of the ATPase module of the 26S proteasome |
| Q27619651 | Structural insights into the mechanism of intramolecular proteolysis |
| Q33737328 | Structure and mechanism of action of the protease that degrades small, acid-soluble spore proteins during germination of spores of Bacillus species. |
| Q27641494 | Structure and reactivity of an asymmetric complex between HslV and I-domain deleted HslU, a prokaryotic homolog of the eukaryotic proteasome |
| Q41535692 | Structure and structure formation of the 20S proteasome |
| Q27735081 | Structure of 20S proteasome from yeast at 2.4 A resolution |
| Q27660222 | Structure of a Blm10 Complex Reveals Common Mechanisms for Proteasome Binding and Gate Opening |
| Q35097624 | Substrate access and processing by the 20S proteasome core particle |
| Q41027912 | Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes |
| Q24311953 | Subunit arrangement in the human 20S proteasome |
| Q34891158 | Subunit oligomerization and substrate recognition of the Escherichia coli ClpYQ (HslUV) protease implicated by in vivo protein-protein interactions in the yeast two-hybrid system |
| Q39702656 | Subunit topology of two 20S proteasomes from Haloferax volcanii |
| Q57007289 | Synthetic peptide conjugates—tailor-made probes for the biology of protein modification and protein processing |
| Q24300473 | Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression |
| Q37083471 | Tea polyphenols and their roles in cancer prevention and chemotherapy |
| Q37070437 | Tea polyphenols, their biological effects and potential molecular targets |
| Q48041490 | The 20S proteasome gene family in Arabidopsis thaliana. |
| Q39568209 | The 20S proteasome of Streptomyces coelicolor. |
| Q28348872 | The ATP-dependent CodWX (HslVU) protease in Bacillus subtilis is an N-terminal serine protease |
| Q43993783 | The C-terminal tails of HslU ATPase act as a molecular switch for activation of HslV peptidase |
| Q73065840 | The Leishmania mexicana proteasome |
| Q33658714 | The Mycobacterium tuberculosis proteasome active site threonine is essential for persistence yet dispensable for replication and resistance to nitric oxide |
| Q38132669 | The RNA exosome and proteasome: common principles of degradation control |
| Q33785026 | The Saccharomyces cerevisiae ubiquitin-proteasome system |
| Q47273976 | The Y. bercovieri Anbu crystal structure sheds light on the evolution of highly (pseudo)symmetric multimers. |
| Q27939678 | The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing |
| Q48964378 | The antitumor drug aclacinomycin A, which inhibits the degradation of ubiquitinated proteins, shows selectivity for the chymotrypsin-like activity of the bovine pituitary 20 S proteasome |
| Q36386004 | The archaeal proteasome is regulated by a network of AAA ATPases |
| Q33187465 | The caspase-like sites of proteasomes, their substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sites. |
| Q30779094 | The catalytic sites of 20S proteasomes and their role in subunit maturation: a mutational and crystallographic study |
| Q70920514 | The fates of proteins in cells |
| Q38819083 | The fine-tuning of proteolytic pathways in Alzheimer's disease |
| Q48072601 | The first characterization of a eubacterial proteasome: the 20S complex of Rhodococcus |
| Q54567772 | The human alpha-type proteasomal subunit HsC8 forms a double ringlike structure, but does not assemble into proteasome-like particles with the beta-type subunits HsDelta or HsBPROS26. |
| Q36065854 | The pore of activated 20S proteasomes has an ordered 7-fold symmetric conformation |
| Q73204803 | The proteasome |
| Q33796158 | The proteasome activator 11 S REG (PA28) and class I antigen presentation |
| Q95650650 | The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges |
| Q33700949 | The proteasome, a novel protease regulated by multiple mechanisms |
| Q33785021 | The proteasome: a macromolecular assembly designed for controlled proteolysis |
| Q36862775 | The proteasome: a macromolecular assembly designed to confine proteolysis to a nanocompartment |
| Q34545602 | The proteasome: a supramolecular assembly designed for controlled proteolysis |
| Q29615187 | The proteasome: paradigm of a self-compartmentalizing protease |
| Q30453898 | The proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides |
| Q27659007 | The quorum-quenching N-acyl homoserine lactone acylase PvdQ is an Ntn-hydrolase with an unusual substrate-binding pocket |
| Q30654582 | The role of alpha-amino group of the N-terminal serine of beta subunit for enzyme catalysis and autoproteolytic activation of glutaryl 7-aminocephalosporanic acid acylase |
| Q37171851 | The roles of the proteasome pathway in signal transduction and neurodegenerative diseases |
| Q51824224 | The solution of nitrogen inversion in amidases. |
| Q36545597 | The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome |
| Q28214433 | The transporter associated with antigen processing: function and implications in human diseases |
| Q37175850 | The tumor proteasome as a novel target for gold(III) complexes: implications for breast cancer therapy |
| Q28367002 | The ubiquitin-proteasome pathway and proteasome inhibitors |
| Q28305844 | The ubiquitin-proteasome system |
| Q29030764 | Thermoplasmatales |
| Q27973422 | Thiostrepton and derivatives exhibit antimalarial and gametocytocidal activity by dually targeting parasite proteasome and apicoplast |
| Q33622430 | Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells |
| Q41062674 | Two-substrate association with the 20S proteasome at single-molecule level |
| Q27931305 | Ump1p is required for proper maturation of the 20S proteasome and becomes its substrate upon completion of the assembly. |
| Q28295493 | Unconventional serine proteases: variations on the catalytic Ser/His/Asp triad configuration |
| Q46763702 | VAT, the thermoplasma homolog of mammalian p97/VCP, is an N domain-regulated protein unfoldase |
| Q61788075 | Variations in proteasome subunit composition and enzymatic activity in B-lymphoma lines and normal B cells |
| Q93089059 | Visualizing Proteasome Activity and Intracellular Localization Using Fluorescent Proteins and Activity-Based Probes |
| Q35127936 | Why Ser and not Thr brokers catalysis in the trypsin fold |
| Q30870481 | Why does threonine, and not serine, function as the active site nucleophile in proteasomes? |
| Q30814900 | alpha5 subunit in Trypanosoma brucei proteasome can self-assemble to form a cylinder of four stacked heptamer rings |
| Q28282975 | cDNA cloning of p42, a shared subunit of two proteasome regulatory proteins, reveals a novel member of the AAA protein family |
| Q22253889 | cDNA cloning, expression, and functional characterization of PI31, a proline-rich inhibitor of the proteasome |
Search more.